The DOI matches its Crossref record; 215 of the 215 references it cites were found in a registry or an index.
Interleukin-17A and Keratinocytes in Psoriasis
Open accessAbstract
The excellent clinical efficacy of anti-interleukin 17A (IL-17A) biologics on psoriasis indicates a crucial pathogenic role of IL-17A in this autoinflammatory skin disease. IL-17A accelerates the proliferation of epidermal keratinocytes. Keratinocytes produce a myriad of antimicrobial peptides and chemokines, such as CXCL1, CXCL2, CXCL8, and CCL20. Antimicrobial peptides enhance skin inflammation. IL-17A is capable of upregulating the production of these chemokines and antimicrobial peptides in keratinocytes. CXCL1, CXCL2, and CXCL8 recruit neutrophils and CCL20 chemoattracts IL-17A-producing CCR6+ immune cells, which further contributes to forming an IL-17A-rich milieu. This feed-forward pathogenic process results in characteristic histopathological features, such as epidermal hyperproliferation, intraepidermal neutrophilic microabscess, and dermal CCR6+ cell infiltration. In this review, we focus on IL-17A and keratinocyte interaction regarding psoriasis pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
The Nuclear Factor NF- B Pathway in Inflammation
Lawrence, T. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001651 · Cited by 4,898
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099 · cited 2×
“In addition, Th17 cells produce high amounts of TNF-α [74,75].”
BackgroundAtopic Dermatitis: Global Epidemiology and Risk Factors
Nutten, S. (2015) · Annals of Nutrition and Metabolism · doi:10.1159/000370220 · Cited by 3,055
Boehncke, W.-H., & Schön, M. P. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61909-7 · Cited by 2,542
Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330
Secukinumab in plaque psoriasis—results of two phase 3 trials
Langley, R. G., Elewski, B. E., Lebwohl, M., Reich, K., Griffiths, C. E. M., Papp, K., Puig, L., Nakagawa, H., Spelman, L., Sigurgeirsson, B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314258 · Cited by 1,997
Endogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis
Ong, P. Y., Ohtake, T., Brandt, C., Strickland, I., Boguniewicz, M., Ganz, T., Gallo, R. L., & Leung, D. Y. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021481 · Cited by 1,960
Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide
Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y.-H., Homey, B., Cao, W., Wang, Y.-H., Su, B., Nestle, F. O., et al. (2007) · Nature · doi:10.1038/nature06116 · Cited by 1,910
Aggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,847
β-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6
Yang, D., Chertov, O., Bykovskaia, S. N., Chen, Q., Buffo, M. J., Shogan, J., Anderson, M., Schröder, J. M., Wang, J. M., Howard, O. M. Z., et al. (1999) · Science · doi:10.1126/science.286.5439.525 · Cited by 1,809
Innate IL-17-producing cells: the sentinels of the immune system
Cua, D. J., & Tato, C. M. (2010) · Nature Reviews Immunology · doi:10.1038/nri2800 · Cited by 1,578
Structure and signalling in the IL-17 receptor family
Gaffen, S. L. (2009) · Nature reviews. Immunology · doi:10.1038/nri2586 · Cited by 1,475
The IL-17 Family of Cytokines in Health and Disease
McGeachy, M. J., Cua, D. J., & Gaffen, S. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.021 · Cited by 1,443
Standardizing immunophenotyping for the Human Immunology Project
Maecker, H. T., McCoy, J. P., & Nussenblatt, R. (2012) · Nature Reviews Immunology · doi:10.1038/nri3158 · Cited by 1,176
A systematic review of worldwide epidemiology of psoriasis
Michalek, I. M., Loring, B., & John, S. M. (2017) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13854 · Cited by 1,150
Chronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity
Puel, A., Cypowyj, S., Bustamante, J., Wright, J. F., Liu, L., Lim, H. K., Migaud, M., Israel, L., Chrabieh, M., Audry, M., et al. (2011) · Science · doi:10.1126/science.1200439 · Cited by 1,056
Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin Inflammation
Cai, Y., Shen, X., Ding, C., Qi, C., Li, K., Li, X., Jala, V. R., Zhang, H.-G., Wang, T., Zheng, J., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.08.001 · Cited by 1,026
Conti, H. R., Shen, F., Nayyar, N., Stocum, E., Sun, J. N., Lindemann, M. J., Ho, A. W., Hai, J. H., Yu, J. J., Jung, J. W., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081463 · Cited by 1,024
Psoriasis pathogenesis and the development of novel targeted immune therapies
Hawkes, J. E., Chan, T. C., & Krueger, J. G. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.07.004 · Cited by 972
Lee, E., Trepicchio, W. L., Oestreicher, J. L., Pittman, D., Wang, F., Chamian, F., Dhodapkar, M., & Krueger, J. G. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20030451 · Cited by 899
Blauvelt, A., Papp, K. A., Griffiths, C. E. M., Randazzo, B., Wasfi, Y., Shen, Y.-K., Li, S., & Kimball, A. B. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.11.041 · Cited by 897
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
Gordon, K. B., Blauvelt, A., Papp, K. A., Langley, R. G., Luger, T., Ohtsuki, M., Reich, K., Amato, D., Ball, S. G., Braun, D. K., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1512711 · Cited by 848
Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
Lebwohl, M., Strober, B., Menter, A., Gordon, K., Weglowska, J., Puig, L., Papp, K., Spelman, L., Toth, D., Kerdel, F., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503824 · Cited by 828
McInnes, I. B., Kavanaugh, A., Gottlieb, A. B., Puig, L., Rahman, P., Ritchlin, C., Brodmerkel, C., Li, S., Wang, Y., Mendelsohn, A. M., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60594-2 · Cited by 807
Nograles, K. E., Zaba, L. C., Guttman-Yassky, E., Fuentes-Duculan, J., Suárez-Fariñas, M., Cardinale, I., Khatcherian, A., Gonzalez, J., Pierson, K. C., White, T. R., et al. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08769.x · Cited by 804
Sano, S., Chan, K. S., Carbajal, S., Clifford, J., Peavey, M., Kiguchi, K., Itami, S., Nickoloff, B. J., & DiGiovanni, J. (2005) · Nature Medicine · doi:10.1038/nm1162 · Cited by 752
Nomura, I., Goleva, E., Howell, M. D., Hamid, Q. A., Ong, P. Y., Hall, C. F., Darst, M. A., Gao, B., Boguniewicz, M., Travers, J. B., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3262 · Cited by 731
Chiricozzi, A., Guttman-Yassky, E., Suárez-Fariñas, M., Nograles, K. E., Tian, S., Cardinale, I., Chimenti, S., & Krueger, J. G. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.340 · Cited by 686
Chan, J. R., Blumenschein, W., Murphy, E., Diveu, C., Wiekowski, M., Abbondanzo, S., Lucian, L., Geissler, R., Brodie, S., Kimball, A. B., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060244 · Cited by 680
Chemokines in pathology and medicine
Baggiolini, M. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00867.x · Cited by 677
Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses
Zaba, L. C., Cardinale, I., Gilleaudeau, P., Sullivan-Whalen, M., Suárez-Fariñas, M., Fuentes-Duculan, J., Novitskaya, I., Khatcherian, A., Bluth, M. J., Lowes, M. A., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20071094 · Cited by 676
Risk Factors for the Development of Psoriasis
Kamiya, K., Kishimoto, M., Sugai, J., Komine, M., & Ohtsuki, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184347 · Cited by 640
Discovery of the IL-23/IL-17 Signaling Pathway and the Treatment of Psoriasis
Hawkes, J. E., Yan, B. Y., Chan, T. C., & Krueger, J. G. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800013 · Cited by 593
The pathogenesis of psoriatic arthritis
Veale, D. J., & Fearon, U. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30830-4 · Cited by 576
Reich, K., Papp, K. A., Blauvelt, A., Tyring, S. K., Sinclair, R., Thaçi, D., Nograles, K., Mehta, A., Cichanowitz, N., Li, Q., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31279-5 · Cited by 569
Dorschner, R. A., Pestonjamasp, V. K., Tamakuwala, S., Ohtake, T., Rudisill, J., Nizet, V., Agerberth, B., Gudmundsson, G. H., & Gallo, R. L. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01340.x · Cited by 567
The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis
Lande, R., Botti, E., Jandus, C., Dojcinovic, D., Fanelli, G., Conrad, C., Chamilos, G., Feldmeyer, L., Marinari, B., Chon, S., et al. (2014) · Nature Communications · doi:10.1038/ncomms6621 · Cited by 539
Management of psoriasis as a systemic disease: what is the evidence?
Korman, N. J. (2020) · British Journal of Dermatology · doi:10.1111/bjd.18245 · Cited by 539
Up-Regulation of Macrophage Inflammatory Protein-3α/CCL20 and CC Chemokine Receptor 6 in Psoriasis
Homey, B., Dieu-Nosjean, M.-C., Wiesenborn, A., Massacrier, C., Pin, J.-J., Oldham, E., Catron, D., Buchanan, M. E., Müller, A., deWaal Malefyt, R., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6621 · Cited by 537
Chronically Inflamed Human Tissues Are Infiltrated by Highly Differentiated Th17 Lymphocytes
Pène, J., Chevalier, S., Preisser, L., Vénéreau, E., Guilleux, M.-H., Ghannam, S., Molès, J.-P., Danger, Y., Ravon, E., Lesaux, S., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7423 · Cited by 527
Sa, S. M., Valdez, P. A., Wu, J., Jung, K., Zhong, F., Hall, L., Kasman, I., Winer, J., Modrusan, Z., Danilenko, D. M., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2229 · Cited by 514
Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis
Papp, K. A., Blauvelt, A., Bukhalo, M., Gooderham, M., Krueger, J. G., Lacour, J.-P., Menter, A., Philipp, S., Sofen, H., Tyring, S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1607017 · Cited by 514
Harper, E. G., Guo, C., Rizzo, H., Lillis, J. V., Kurtz, S. E., Skorcheva, I., Purdy, D., Fitch, E., Iordanov, M., & Blauvelt, A. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.65 · Cited by 508
IL-17C regulates the innate immune function of epithelial cells in an autocrine manner
Ramirez-Carrozzi, V., Sambandam, A., Luis, E., Lin, Z., Jeet, S., Lesch, J., Hackney, J., Kim, J., Zhou, M., Lai, J., et al. (2011) · Nature Immunology · doi:10.1038/ni.2156 · Cited by 477
The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond
Brembilla, N. C., Senra, L., & Boehncke, W.-H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01682 · Cited by 475
Basic biology and role of interleukin‐17 in immunity and inflammation
Zenobia, C., & Hajishengallis, G. (2015) · Periodontology 2000 · doi:10.1111/prd.12083 · Cited by 470
Tsoi, L. C., Rodriguez, E., Degenhardt, F., Baurecht, H., Wehkamp, U., Volks, N., Szymczak, S., Swindell, W. R., Sarkar, M. K., Raja, K., et al. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.12.018 · Cited by 469 · cited 2×
“However, IL-17A is believed to be the most pathogenic IL-17 family member in psoriasis [68,69,72,73,143].”
BackgroundThe Emerging Role of IL-17 in the Pathogenesis of Psoriasis: Preclinical and Clinical Findings
Martin, D. A., Towne, J. E., Kricorian, G., Klekotka, P., Gudjonsson, J. E., Krueger, J. G., & Russell, C. B. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.194 · Cited by 466
Pathogenesis of psoriasis and development of treatment
Ogawa, E., Sato, Y., Minagawa, A., & Okuyama, R. (2018) · The Journal of Dermatology · doi:10.1111/1346-8138.14139 · Cited by 456
Piskin, G., Sylva-Steenland, R. M. R., Bos, J. D., & Teunissen, M. B. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1908 · Cited by 454
Carrier, Y., Ma, H.-L., Ramon, H. E., Napierata, L., Small, C., O'Toole, M., Young, D. A., Fouser, L. A., Nickerson-Nutter, C., Collins, M., et al. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.234 · Cited by 425
IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis
Johnston, A., Xing, X., Wolterink, L., Barnes, D. H., Yin, Z., Reingold, L., Kahlenberg, J. M., Harms, P. W., & Gudjonsson, J. E. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.08.056 · Cited by 397
Villanova, F., Flutter, B., Tosi, I., Grys, K., Sreeneebus, H., Perera, G. K., Chapman, A., Smith, C. H., Di Meglio, P., & Nestle, F. O. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.477 · Cited by 386
IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis
Krueger, J. G., Fretzin, S., Suárez-Fariñas, M., Haslett, P. A., Phipps, K. M., Cameron, G. S., McColm, J., Katcherian, A., Cueto, I., White, T., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.04.024 · Cited by 383
Human T Cells That Are Able to Produce IL-17 Express the Chemokine Receptor CCR6
Singh, S. P., Zhang, H. H., Foley, J. F., Hedrick, M. N., & Farber, J. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.1.214 · Cited by 371
Melanocyte antigen triggers autoimmunity in human psoriasis
Arakawa, A., Siewert, K., Stöhr, J., Besgen, P., Kim, S.-M., Rühl, G., Nickel, J., Vollmer, S., Thomas, P., Krebs, S., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20151093 · Cited by 361
Tokumaru, S., Sayama, K., Shirakata, Y., Komatsuzawa, H., Ouhara, K., Hanakawa, Y., Yahata, Y., Dai, X., Tohyama, M., Nagai, H., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4662 · Cited by 358
Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin
Johansen, C., Usher, P. A., Kjellerup, R. B., Lundsgaard, D., Iversen, L., & Kragballe, K. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08902.x · Cited by 352
The Koebner phenomenon: review of the literature
Weiss, G. J., Shemer, A., & Trau, H. (2002) · Journal of the European Academy of Dermatology and Venereology · doi:10.1046/j.1473-2165.2002.00406.x · Cited by 351
Neutrophil-Derived Proteases Escalate Inflammation through Activation of IL-36 Family Cytokines
Henry, C. M., Sullivan, G. P., Clancy, D. M., Afonina, I. S., Kulms, D., & Martin, S. J. (2016) · Cell Reports · doi:10.1016/j.celrep.2015.12.072 · Cited by 330
Johnston, A., Xing, X., Guzman, A. M., Riblett, M., Loyd, C. M., Ward, N. L., Wohn, C., Prens, E. P., Wang, F., Maier, L. E., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003162 · Cited by 319
Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation
Johnston, A., Fritz, Y., Dawes, S. M., Diaconu, D., Al-Attar, P. M., Guzman, A. M., Chen, C. S., Fu, W., Gudjonsson, J. E., McCormick, T. S., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201505 · Cited by 308
Identification of Sef, a novel modulator of FGF signalling
Tsang, M., Friesel, R., Kudoh, T., & Dawid, I. B. (2002) · Nature Cell Biology · doi:10.1038/ncb749 · Cited by 304
IL-17–Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans
Conti, H. R., & Gaffen, S. L. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500909 · Cited by 301
Boisson, B., Wang, C., Pedergnana, V., Wu, L., Cypowyj, S., Rybojad, M., Belkadi, A., Picard, C., Abel, L., Fieschi, C., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.09.002 · Cited by 293
Inhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis
Bachelez, H., Choon, S.-E., Marrakchi, S., Burden, A. D., Tsai, T.-F., Morita, A., Turki, H., Hall, D. B., Shear, M., Baum, P., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmc1811317 · Cited by 292 · cited 1×
“In parallel, inhibition of the IL-36 pathway is efficacious for the treatment of pustular psoriasis [201].”
BackgroundNedoszytko, B., Sokołowska-Wojdyło, M., Ruckemann-Dziurdzińska, K., Roszkiewicz, J., & Nowicki, R. J. (2014) · Advances in Dermatology and Allergology · doi:10.5114/pdia.2014.40920 · Cited by 292
de Jongh, G. J., Zeeuwen, P. L. J. M., Kucharekova, M., Pfundt, R., van der Valk, P. G., Blokx, W., Dogan, A., Hiemstra, P. S., van de Kerkhof, P. C., & Schalkwijk, J. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23935.x · Cited by 285
Interleukin-17C Promotes Th17 Cell Responses and Autoimmune Disease via Interleukin-17 Receptor E
Chang, S. H., Reynolds, J. M., Pappu, B. P., Chen, G., Martinez, G. J., & Dong, C. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.010 · Cited by 271
Karbach, S., Croxford, A. L., Oelze, M., Schüler, R., Minwegen, D., Wegner, J., Koukes, L., Yogev, N., Nikolaev, A., Reißig, S., et al. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.304108 · Cited by 261
Krueger, J. G., Ferris, L. K., Menter, A., Wagner, F., White, A., Visvanathan, S., Lalovic, B., Aslanyan, S., Wang, E. E. L., Hall, D., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.01.018 · Cited by 256
Sparber, F., De Gregorio, C., Steckholzer, S., Ferreira, F. M., Dolowschiak, T., Ruchti, F., Kirchner, F. R., Mertens, S., Prinz, I., Joller, N., et al. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.02.002 · Cited by 255
Cheung, K. L., Jarrett, R., Subramaniam, S., Salimi, M., Gutowska-Owsiak, D., Chen, Y.-L., Hardman, C., Xue, L., Cerundolo, V., & Ogg, G. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20160258 · Cited by 249
Psoriasis: A STAT3-Centric View
Calautti, E., Avalle, L., & Poli, V. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010171 · Cited by 246
β-Defensin 2 is a responsive biomarker of IL-17A–driven skin pathology in patients with psoriasis
Kolbinger, F., Loesche, C., Valentin, M.-A., Jiang, X., Cheng, Y., Jarvis, P., Peters, T., Calonder, C., Bruin, G., Polus, F., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.06.038 · Cited by 238
Cathelicidin LL-37: An Antimicrobial Peptide with a Role in Inflammatory Skin Disease
Reinholz, M., Ruzicka, T., & Schauber, J. (2012) · Annals of Dermatology · doi:10.5021/ad.2012.24.2.126 · Cited by 236
Miyoshi, K., Takaishi, M., Nakajima, K., Ikeda, M., Kanda, T., Tarutani, M., Iiyama, T., Asao, N., DiGiovanni, J., & Sano, S. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.255 · Cited by 235
Regulation and function of interleukin-36 cytokines in homeostasis and pathological conditions
Gabay, C., & Towne, J. E. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ri1014-495r · Cited by 228
Gläser, R., Meyer-Hoffert, U., Harder, J., Cordes, J., Wittersheim, M., Kobliakova, J., Fölster-Holst, R., Proksch, E., Schröder, J.-M., & Schwarz, T. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.268 · Cited by 214
Imiquimod-Induced Psoriasis in Mice Depends on the IL-17 Signaling of Keratinocytes
Moos, S., Mohebiany, A. N., Waisman, A., & Kurschus, F. C. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.01.006 · Cited by 204
Inherited IL-17RC deficiency in patients with chronic mucocutaneous candidiasis
Ling, Y., Cypowyj, S., Aytekin, C., Galicchio, M., Camcioglu, Y., Nepesov, S., Ikinciogullari, A., Dogu, F., Belkadi, A., Levy, R., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141065 · Cited by 192
Krueger, J. G., Wharton, K. A., Schlitt, T., Suprun, M., Torene, R. I., Jiang, X., Wang, C. Q., Fuentes-Duculan, J., Hartmann, N., Peters, T., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.04.029 · Cited by 188
Modulation of Cell Proliferation by Cytokeratins K10 and K16
Paramio, J. M., Casanova, M. L., Segrelles, C., Mittnacht, S., Lane, E. B., & Jorcano, J. L. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.3086 · Cited by 182
IL-17 Induces an Expanded Range of Downstream Genes in Reconstituted Human Epidermis Model
Chiricozzi, A., Nograles, K. E., Johnson-Huang, L. M., Fuentes-Duculan, J., Cardinale, I., Bonifacio, K. M., Gulati, N., Mitsui, H., Guttman-Yassky, E., Suárez-Fariñas, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090284 · Cited by 180
Hu, Y., Ota, N., Peng, I., Refino, C. J., Danilenko, D. M., Caplazi, P., & Ouyang, W. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903614 · Cited by 174
Anti-Infective Protective Properties of S100 Calgranulins
Hsu, K., Champaiboon, C., Guenther, B., Sorenson, B., Khammanivong, A., Ross, K., Geczy, C., & Herzberg, M. (2009) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/187152309789838975 · Cited by 172
IL-17 drives psoriatic inflammation via distinct, target cell-specific mechanisms
Ha, H.-L., Wang, H., Pisitkun, P., Kim, J.-C., Tassi, I., Tang, W., Morasso, M. I., Udey, M. C., & Siebenlist, U. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400513111 · Cited by 171
Mabuchi, T., Takekoshi, T., & Hwang, S. T. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101817 · Cited by 170
Yang, L., Fan, X., Cui, T., Dang, E., & Wang, G. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.05.015 · Cited by 169
Galbraith, G. M. P. (2009) · Yearbook of Dermatology and Dermatologic Surgery · doi:10.1016/s0093-3619(09)79289-5 · Cited by 167
Chronic mucocutaneous candidiasis disease associated with inborn errors of IL‐17 immunity
Okada, S., Puel, A., Casanova, J., & Kobayashi, M. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.71 · Cited by 167
T cell responses in psoriasis and psoriatic arthritis
Diani, M., Altomare, G. F., & Reali, E. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.11.012 · Cited by 165
Hu, S. C.-S., Yu, H.-S., Yen, F.-L., Lin, C.-L., Chen, G.-S., & Lan, C.-C. E. (2016) · Scientific Reports · doi:10.1038/srep31119 · Cited by 165
IL-19 Is a Component of the Pathogenetic IL-23/IL-17 Cascade in Psoriasis
Witte, E., Kokolakis, G., Witte, K., Philipp, S., Doecke, W.-D., Babel, N., Wittig, B. M., Warszawska, K., Kurek, A., Erdmann-Keding, M., et al. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.308 · Cited by 164
Su, Y., Huang, J., Zhao, X., Li, J., Wang, W., Yang, X. O., Shi, Y., Wang, X., Lai, Y., & Dong, C. (2019) · Science Immunology · doi:10.1126/sciimmunol.aau9657 · Cited by 163
Consensus Guidelines for the Management of Plaque Psoriasis
Hsu, S. (2012) · Archives of Dermatology · doi:10.1001/archdermatol.2011.1410 · Cited by 161
Sawyer, L. M., Malottki, K., Sabry-Grant, C., Yasmeen, N., Wright, E., Sohrt, A., Borg, E., & Warren, R. B. (2019) · PLOS ONE · doi:10.1371/journal.pone.0220868 · Cited by 161
Nardo, A. D., Braff, M. H., Taylor, K. R., Na, C., Granstein, R. D., McInturff, J. E., Krutzik, S. R., Modlin, R. L., & Gallo, R. L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1829 · Cited by 159
Mabuchi, T., Singh, T. P., Takekoshi, T., Jia, G.-F., Wu, X., Kao, M. C., Weiss, I. D., Farber, J. M., & Hwang, S. T. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.260 · Cited by 158
Tomasinsig, L., Pizzirani, C., Skerlavaj, B., Pellegatti, P., Gulinelli, S., Tossi, A., Virgilio, F. D., & Zanetti, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802185200 · Cited by 158
Wang, M., Zhang, S., Zheng, G., Huang, J., Songyang, Z., Zhao, X., & Lin, X. (2018) · Immunity · doi:10.1016/j.immuni.2018.05.012 · Cited by 155
Shi, X., Jin, L., Dang, E., Chang, T., Feng, Z., Liu, Y., & Wang, G. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.222 · Cited by 152
IL-17-induced NF-κB Activation via CIKS/Act1
Sønder, S. U., Saret, S., Tang, W., Sturdevant, D. E., Porcella, S. F., & Siebenlist, U. K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.199547 · Cited by 149
Li, N., Yamasaki, K., Saito, R., Fukushi, S., Shimada‐Omori, R., Asano, M., & Aiba, S. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302574 · Cited by 148
The Significance of IL-36 Hyperactivation and IL-36R Targeting in Psoriasis
Madonna, S., Girolomoni, G., Dinarello, C. A., & Albanesi, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133318 · Cited by 148
Epigenetic control of IL-23 expression in keratinocytes is important for chronic skin inflammation
Li, H., Yao, Q., Mariscal, A. G., Wu, X., Huelse, J. M., Pedersen, E., Helin, K., Waisman, A., Vinkel, C., Thomsen, S. F., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03704-z · Cited by 142
Steel, K. J. A., Srenathan, U., Ridley, M., Durham, L. E., Wu, S., Ryan, S. E., Hughes, C., Chan, E., Kirkham, B. W., & Taams, L. S. (2019) · Arthritis & Rheumatology · doi:10.1002/art.41156 · Cited by 142
Hegyi, Z., Zwicker, S., Bureik, D., Perić, M., Koglin, S., Batycka-Baran, A., Prinz, J. C., Ruzicka, T., Schauber, J., & Wolf, R. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.486 · Cited by 140
Safety of biologics in psoriasis
Kamata, M., & Tada, Y. (2017) · The Journal of Dermatology · doi:10.1111/1346-8138.14096 · Cited by 136
Pfaff, C. M., Marquardt, Y., Fietkau, K., Baron, J. M., & Lüscher, B. (2017) · Scientific Reports · doi:10.1038/s41598-017-15892-7 · Cited by 135
Fuentes‐Duculan, J., Bonifacio, K. M., Hawkes, J. E., Kunjravia, N., Cueto, I., Li, X., Gonzalez, J., Garcet, S., & Krueger, J. G. (2017) · Experimental Dermatology · doi:10.1111/exd.13378 · Cited by 129
Interleukin 17, inflammation, and cardiovascular risk in patients with psoriasis
Lockshin, B., Balagula, Y., & Merola, J. F. (2018) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.02.040 · Cited by 126
S100A8/A9, a key mediator for positive feedback growth stimulation of normal human keratinocytes
Nukui, T., Ehama, R., Sakaguchi, M., Sonegawa, H., Katagiri, C., Hibino, T., & Huh, N. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21639 · Cited by 124
The CCL20 and CCR6 axis in psoriasis
Furue, K., Ito, T., Tsuji, G., Nakahara, T., & Furue, M. (2019) · Scandinavian Journal of Immunology · doi:10.1111/sji.12846 · Cited by 122
Self-citationHighlighting Interleukin-36 Signalling in Plaque Psoriasis and Pustular Psoriasis
Furue, K., Yamamura, K., Tsuji, G., Mitoma, C., Uchi, H., Nakahara, T., KIDO-NAKAHARA, M., Kadono, T., & Furue, M. (2017) · Acta Dermato Venereologica · doi:10.2340/00015555-2808 · Cited by 118
Self-citationKrueger, J. G., & Brunner, P. M. (2017) · Experimental Dermatology · doi:10.1111/exd.13467 · Cited by 118
Vandeghinste, N., Klattig, J., Jagerschmidt, C., Lavazais, S., Marsais, F., Haas, J. D., Auberval, M., Lauffer, F., Moran, T., Ongenaert, M., et al. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.01.036 · Cited by 117
Ohtsuki, M., Kubo, H., Morishima, H., Goto, R., Zheng, R., & Nakagawa, H. (2018) · The Journal of Dermatology · doi:10.1111/1346-8138.14504 · Cited by 114
Inborn errors of immunity underlying fungal diseases in otherwise healthy individuals
Li, J., Vinh, D. C., Casanova, J., & Puel, A. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.10.016 · Cited by 113
Matsuzaki, G., & Umemura, M. (2017) · Microbiology and Immunology · doi:10.1111/1348-0421.12560 · Cited by 113
“Inflammatory skin march” in atopic dermatitis and psoriasis
Furue, M., & Kadono, T. (2017) · Inflammation Research · doi:10.1007/s00011-017-1065-z · Cited by 112
Self-citationMiller, R. A. (1982) · International Journal of Dermatology · doi:10.1111/j.1365-4362.1982.tb02070.x · Cited by 109
Chiricozzi, A., Suárez‐Fariñas, M., Fuentes‐Duculan, J., Cueto, I., Li, K., Tian, S., Brodmerkel, C. M., & Krueger, J. G. (2015) · British Journal of Dermatology · doi:10.1111/bjd.14034 · Cited by 108
IL-17R-EGFR axis links wound healing to tumorigenesis in Lrig1+ stem cells
Chen, X., Cai, G., Liu, C., Zhao, J., Gu, C., Wu, L., Hamilton, T. A., Zhang, C.-J., Ko, J., Zhu, L., et al. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20171849 · Cited by 106
Current developments in phototherapy for psoriasis
Morita, A. (2018) · The Journal of Dermatology · doi:10.1111/1346-8138.14213 · Cited by 102
Bando, J. K., Gilfillan, S., Song, C., McDonald, K. G., Huang, S. C., Newberry, R. D., Kobayashi, Y., Allan, D., Carlyle, J. R., Cella, M., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.04.012 · Cited by 99
Honma, M., Minami‐Hori, M., Takahashi, H., & Iizuka, H. (2011) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2011.11.011 · Cited by 96
Johnston, A. W. B., Gudjonsson, J. E., Aphale, A., Guzman, A. M., Stoll, S. W., & Elder, J. T. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.313 · Cited by 94
Kim, T., Jee, H., Fuentes‐Duculan, J., Wu, W. H., Byamba, D., Kim, D., Kim, D. Y., Lew, D., Yang, W.-I., Krueger, J. G., et al. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.534 · Cited by 88
Mast Cell and Monocyte Recruitment by S100A12 and Its Hinge Domain
Yan, W. X., Armishaw, C. J., Goyette, J., Yang, Z., Cai, H., Alewood, P. F., & Geczy, C. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710388200 · Cited by 87
Mutual upregulation of endothelin‐1 and IL ‐25 in atopic dermatitis
Aktar, M. K., Kido‐Nakahara, M., Furue, M., & Nakahara, T. (2015) · Allergy · doi:10.1111/all.12633 · Cited by 84
Self-citationTakahashi, T., Kulkarni, N. N., Lee, E. Y., Zhang, L., Wong, G. C. L., & Gallo, R. L. (2018) · Scientific Reports · doi:10.1038/s41598-018-22409-3 · Cited by 84
Schüler, R., Brand, A., Klebow, S., Wild, J., Veras, F. P., Ullmann, E., Roohani, S., Kolbinger, F., Kossmann, S., Wohn, C., et al. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.09.021 · Cited by 84
Psoriasis and the TNF/IL23/IL17 axis
Furue, K., Ito, T., Tsuji, G., Kadono, T., & Furue, M. (2019) · Giornale Italiano di Dermatologia e Venereologia · doi:10.23736/s0392-0488.18.06202-8 · Cited by 84
Self-citationPsoriasis disease severity measures: comparing efficacy of treatments for severe psoriasis
Weisman, S. M., Pollack, C., & Gottschalk, R. (2003) · Journal of Dermatological Treatment · doi:10.1080/09546630310013360 · Cited by 82
Furue, K., Ito, T., & Furue, M. (2018) · Cytokine · doi:10.1016/j.cyto.2018.08.025 · Cited by 82
Self-citationWójcik, P., Biernacki, M., Wroński, A., Łuczaj, W., Waeg, G., Žarković, N., & Skrzydlewska, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174249 · Cited by 81
Paladini, R. D., & Coulombe, P. A. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.4.1035 · Cited by 80
Guttman‐Yassky, E., & Krueger, J. G. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.02.037 · Cited by 80
Muhr, P., Zeitvogel, J., Heitland, I., Werfel, T., & Wittmann, M. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10302.x · Cited by 78
Buckley, K. M., Ho, E. C. H., Hibino, T., Schrankel, C. S., Schuh, N. W., Wang, G., & Rast, J. P. (2017) · eLife · doi:10.7554/elife.23481 · Cited by 77
Ishida‐Yamamoto, A., & Iizuka, H. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12665870 · Cited by 77
Autoimmunity and autoimmune co‐morbidities in psoriasis
Furue, K., Ito, T., Tsuji, G., Kadono, T., Nakahara, T., & Furue, M. (2018) · Immunology · doi:10.1111/imm.12891 · Cited by 76
Self-citationIncreased frequency of activated CD8+ T cell effectors in patients with psoriatic arthritis
Diani, M., Casciano, F., Marongiu, L., Longhi, M., Altomare, A., Pigatto, P. D. M., Secchiero, P., Gambari, R., Banfi, G., Manfredi, A. A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-47310-5 · Cited by 74
IL-17 and IL-22 Promote Keratinocyte Stemness in the Germinative Compartment in Psoriasis
Ekman, A., Bivik, C. A., Rundquist, I., & Enerbäck, C. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.01.014 · Cited by 73
Interleukin-17-induced protein lipocalin 2 is dispensable for immunity to oral candidiasis
Ferreira, M. C., Whibley, N., Mamo, A. J., Siebenlist, U., Chan, Y. R., & Gaffen, S. L. (2014) · Infection and Immunity · doi:10.1128/iai.01389-13 · Cited by 72
Ghannam, S., Déjou, C., Pedretti, N., Giot, J.-P., Dorgham, K., Boukhaddaoui, H., Deleuze, V., Bernard, F., Jørgensen, C., Yssel, H., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000597 · Cited by 72
Muromoto, R., Hirao, T., Tawa, K., Hirashima, K., Kon, S., Kitai, Y., & Matsuda, T. (2016) · International Immunology · doi:10.1093/intimm/dxw011 · Cited by 72
Kulke, R., Tödt-Pingel, I., Rademacher, D., Röwert, J., Schröder, J., & Christophers, E. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12343916 · Cited by 67
Villegas, J. A., Bayer, A. C., Ider, K., Bismuth, J., Truffault, F., Roussin, R., Santelmo, N., Panse, R. L., Berrih‐Aknin, S., & Dragin, N. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.11.005 · Cited by 62
The Genetics of Psoriasis and Psoriatic Arthritis
O’Rielly, D. D., Jani, M., Rahman, P., & Elder, J. T. (2019) · The Journal of Rheumatology · doi:10.3899/jrheum.190119 · Cited by 62
IL-23 activates innate lymphoid cells to promote neonatal intestinal pathology
Chen, L., He, Z., Slinger, E., Bongers, G., Lapenda, T. L. S., Pacer, M. E., Jiao, J., Beltrão, M., Soto, A. J., Harpaz, N., et al. (2014) · Mucosal Immunology · doi:10.1038/mi.2014.77 · Cited by 60
Characterization of Lamprey IL-17 Family Members and Their Receptors
Han, Q., Das, S., Hirano, M., Holland, S. J., McCurley, N., Guo, P., Rosenberg, C. S., Boehm, T., & Cooper, M. D. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500892 · Cited by 60
Acciani, T. H., Suzuki, T., Trapnell, B. C., & Cras, T. D. L. (2015) · Clinical & Experimental Allergy · doi:10.1111/cea.12612 · Cited by 59
IκB‐ζ: An Inducible Regulator of Nuclear Factor‐κB
Muta, T. (2006) · Vitamins and hormones · doi:10.1016/s0083-6729(06)74012-2 · Cited by 57
IL-17–Secreting γδ T Cells Are Completely Dependent upon CCR6 for Homing to Inflamed Skin
Campbell, J. J., Ebsworth, K., Ertl, L. S., McMahon, J. P., Newland, D., Wang, Y., Liu, S., Miao, Z., Dang, T., Zhang, P., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700826 · Cited by 57
Ito, T., Takahashi, H., Kawada, A., Iizuka, H., & Nakagawa, H. (2017) · The Journal of Dermatology · doi:10.1111/1346-8138.14105 · Cited by 57
Mouse models of psoriasis and their relevance
Nakajima, K., & Sano, S. (2017) · The Journal of Dermatology · doi:10.1111/1346-8138.14112 · Cited by 57
House, J. S., Zhu, S., Ranjan, R., Linder, K. E., & Smart, R. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009837 · Cited by 55
Liu, C., Swaidani, S., Wen, Q., Kang, Z., Sun, P., Han, Y., Wang, C., Gulen, M. F., Yin, W., Zhang, C., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001843 · Cited by 55
Sun, D., Yeh, C., So, E. C., Wang, L.-Y., Wei, T.-S., Chang, M., & Hsing, C. (2013) · Cytokine · doi:10.1016/j.cyto.2013.03.017 · Cited by 54
S100A7: A rAMPing up AMP molecule in psoriasis
D’Amico, F., Skarmoutsou, E., Granata, M., Trovato, C., Rossi, G. A., & Mazzarino, M. C. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.01.002 · Cited by 54
Cordoro, K. M., Hitraya‐Low, M., Taravati, K., Sandoval, P. M., Kim, E., Sugarman, J., Pauli, M. L., Liao, W. J., & Rosenblum, M. D. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2017.05.017 · Cited by 54
Imafuku, S., Zheng, M., Tada, Y., Zhang, X., Theng, C., Thevarajah, S., Zhao, Y., & Song, H. J. (2018) · The Journal of Dermatology · doi:10.1111/1346-8138.14338 · Cited by 53
Erichsen, C. Y., Jensen, P. E. H., & Kofoed, K. F. (2019) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.15879 · Cited by 53
Furue, K., Ito, T., Tanaka, Y., Yumine, A., Hashimoto‐Hachiya, A., Takemura, M., Murata, M., Yamamura, K., Tsuji, G., & Furue, M. (2019) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2019.04.002 · Cited by 50
Self-citationBouma, G., Zamuner, S., Hicks, K. J., Want, A., de Oliveira, J. J., Choudhury, A., Brett, S. J., Robertson, D. C., Felton, L. M., Norris, V., et al. (2017) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13286 · Cited by 47
TNFα ‐ and IL ‐17A‐mediated S100 A 8 expression is regulated by p38 MAPK
Mose, M., Kang, Z., Raaby, L., Iversen, L., & Johansen, C. (2013) · Experimental Dermatology · doi:10.1111/exd.12187 · Cited by 46
Increased risk of psoriasis in subjects with abdominal obesity: A nationwide population‐based study
Han, J. H., Lee, J. H., Han, K., Kim, H., Bang, C. H., Park, Y. M., Lee, J. Y., & Kim, T. Y. (2019) · The Journal of Dermatology · doi:10.1111/1346-8138.14939 · Cited by 46
Patient preference for biologic treatments of psoriasis in Japan
Tada, Y., Ishii, K., Kimura, J., Hanada, K., & Kawaguchi, I. (2019) · The Journal of Dermatology · doi:10.1111/1346-8138.14870 · Cited by 45
Crish, J. F., Gopalakrishnan, R., Bone, F., Gilliam, A. C., & Eckert, R. L. (2005) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700019 · Cited by 42
Talayero, P., Mancebo, E., Calvo, J., Rodríguez-Muñoz, S., Bernardo, I., Laguna‐Goya, R., Cano-Romero, F. L., García‐Sesma, Á., Loinaz, C., Jiménez, C., et al. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13435 · Cited by 40
Jung, K. J., Kim, T., Lee, J. W., Lee, M., Oh, J., Lee, S., Chang, H., Jee, S. H., & Lee, M. (2019) · The Journal of Dermatology · doi:10.1111/1346-8138.15052 · Cited by 38
Binding Affinity and Interaction of LL-37 with HLA-C*06:02 in Psoriasis
Mabuchi, T., & Hirayama, N. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.04.033 · Cited by 35
The human IL ‐17A/F heterodimer regulates psoriasis‐associated genes through IκBζ
Bertelsen, T., Iversen, L., & Johansen, C. (2018) · Experimental Dermatology · doi:10.1111/exd.13722 · Cited by 35
Bayaraa, B., & Imafuku, S. (2019) · The Journal of Dermatology · doi:10.1111/1346-8138.14834 · Cited by 34
Robert, R., Ang, C., Sun, G., Juglair, L., Lim, E. X., Mason, L. J., Payne, N. L., Bernard, C. C. A., & Mackay, C. R. (2017) · JCI Insight · doi:10.1172/jci.insight.94821 · Cited by 33
Yunusbaeva, M. M., Valiev, R., Bilalov, F. S., Султанова, З. И., Sharipova, L., & Yunusbayev, B. (2018) · Scientific Reports · doi:10.1038/s41598-018-24491-z · Cited by 33
IL-17 promotes keratinocyte proliferation via the downregulation of C/EBPα
Ma, W., JIA, K., & Zhang, Y. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2939 · Cited by 32
Kamata, M., Asano, Y., Shida, R., Maeda, N., Yoshizaki, A., Miyagaki, T., Kawashima, T., Tada, Y., & Sato, S. (2019) · The Journal of Dermatology · doi:10.1111/1346-8138.14760 · Cited by 32
Furue, K., Ito, T., Tanaka, Y., Hashimoto‐Hachiya, A., Takemura, M., Murata, M., Kido‐Nakahara, M., Tsuji, G., Nakahara, T., & Furue, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020434 · Cited by 31
Self-citationMomose, M., Asahina, A., Umezawa, Y., & Nakagawa, H. (2017) · The Journal of Dermatology · doi:10.1111/1346-8138.14145 · Cited by 28
Warren, R. B., Barker, J., Finlay, A. Y., Burden, A. D., Kirby, B., Armendáriz, Y., Williams, R., Hatchard, C., Khare, S., & Griffiths, C. E. M. (2019) · British Journal of Dermatology · doi:10.1111/bjd.18623 · Cited by 28
Ho, Y., Hu, H., Chang, Y.-T., Li, C., & Wu, C. (2019) · The Journal of Dermatology · doi:10.1111/1346-8138.14902 · Cited by 27
The contribution of IL-17 to the development of autoimmunity in psoriasis
Furue, M., & Kadono, T. (2019) · Innate Immunity · doi:10.1177/1753425919852156 · Cited by 27
Self-citationBayaraa, B., & Imafuku, S. (2018) · The Journal of Dermatology · doi:10.1111/1346-8138.14321 · Cited by 26
CALDWELL, C. J., Hobbs, C., & McKee, P. H. (1997) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.1997.d01-232.x · Cited by 25
Efficacy of Chemokine Receptor Inhibition in Treating IL-36α–Induced Psoriasiform Inflammation
Campbell, J. J., Ebsworth, K., Ertl, L. S., McMahon, J. P., Wang, Y., Yau, S., Mali, V. R., Chhina, V., Kumamoto, A., Liu, S., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801519 · Cited by 25
Diani, M., Perego, S., Sansoni, V., Bertino, L., Gomarasca, M., Faraldi, M., Pigatto, P. D. M., Damiani, G. B., Banfi, G., Altomare, G. F., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225617 · Cited by 25
Ichiyama, S., Ito, M., Funasaka, Y., Abe, M., Nishida, E., Muramatsu, S., Nishihara, H., Kato, H., Morita, A., Imafuku, S., et al. (2018) · The Journal of Dermatology · doi:10.1111/1346-8138.14225 · Cited by 24
Takamura, S., Takahashi, A., Inoue, Y., & Teraki, Y. (2018) · The Journal of Dermatology · doi:10.1111/1346-8138.14526 · Cited by 24
Okubo, Y., Ohtsuki, M., Morita, A., Yamaguchi, M., Shima, T., Tani, Y., Nakagawa, H., & Subgroup, E. S. J. (2019) · The Journal of Dermatology · doi:10.1111/1346-8138.14761 · Cited by 24
RIP4 upregulates CCL20 expression through STAT3 signalling in cultured keratinocytes
Bae, H. C., Jeong, S. H., Kim, J. H., Lee, H., Ryu, W., Kim, M., Son, E. D., Lee, T. R., & Son, S. W. (2018) · Experimental Dermatology · doi:10.1111/exd.13750 · Cited by 23
Assefa, G. T., Kaneko, S., Oguro, H., & Morita, E. (2018) · The Journal of Dermatology · doi:10.1111/1346-8138.14619 · Cited by 22
Epidemiological survey of patients with psoriasis in Matsumoto city, Nagano Prefecture, Japan
Ogawa, E., Okuyama, R., Seki, T., Kobayashi, A., Oiso, N., Muto, M., Nakagawa, H., & Kawada, A. (2017) · The Journal of Dermatology · doi:10.1111/1346-8138.14101 · Cited by 20
Yamamoto, T., & Kawada, A. (2017) · The Journal of Dermatology · doi:10.1111/1346-8138.14097 · Cited by 20
Elder, J. T. (2018) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1016/j.jisp.2018.09.005 · Cited by 20
Tu, Z., Zhang, S., Zhou, G., Zhou, L., Xiang, Q., Chen, Q., Zhao, P., Zhan, H.-Q., Zhou, H., & Sun, L. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.12.010 · Cited by 19
Lee, M., Huang, Y., Lee, J., Lee, S., Kim, T., Aw, D. C., Bao, W., Dee, C. M. A., Guana, A., & Tsai, T. (2019) · The Journal of Dermatology · doi:10.1111/1346-8138.15004 · Cited by 19
Cited by
Advances in the pathogenesis of psoriasis: from keratinocyte perspective
Zhou, X., Chen, Y., Cui, L., Shi, Y., & Guo, C. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-04523-3 · Cited by 632
Signaling pathways and targeted therapies for psoriasis
Guo, J., Zhang, H., Lin, W., Lu, L., Su, J., & Chen, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01655-6 · Cited by 427
Cytokinocytes: the diverse contribution of keratinocytes to immune responses in skin
Jiang, Y., Tsoi, L. C., Billi, A. C., Ward, N. L., Harms, P. W., Zeng, C., Maverakis, E., Kahlenberg, J. M., & Gudjonsson, J. E. (2020) · JCI Insight · doi:10.1172/jci.insight.142067 · Cited by 348
Current Concepts of Psoriasis Immunopathogenesis
Vičić, M., Kaštelan, M., Brajac, I., Sotošek, V., & Massari, L. P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111574 · Cited by 163
Tsuji, G., Yamamura, K., Kawamura, K., Kido-Nakahara, M., Ito, T., & Nakahara, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914633 · Cited by 21
Self-citation
Metadata
- Authors
- Furue, M., Furue, K., Tsuji, G., & Nakahara, T.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-02-13
- Volume
- 21
- Issue
- 4
- Pages
- 1275
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3006622277
- Cited by
- 300
- References
- 215
- FWCI
- 9.75
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.